-
Abbvie’s Viekira Pak Costs $6.5 Million a Year in Avoidable Costs, Puts Patients at Greater Risk
Abbvie’s Viekira Pak Costs $6.5 Million a Year in Avoidable Costs, Puts Patients at Greater […]
-
The Non-Negotiable Cost of Drugs
In the past several months the “war on drugs” has intensified. But the war is […]
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Blame Canada
First, a disclosure. I am Canadian. Well, I’m actually a dual U.S. – Canadian citizen. […]
-
A Drug Safety Call to Arms
Last week, the Institute for Safe Medical Practices (ISMP) published an alarming report exposing the dirty […]
-
Health IT, MedCity Influencers
Will 2015 really be the year of healthcare technology?
“21st century businesses will rely on American science, technology, research and development. I want the […]
-
OpenFDA: What’s good, what’s bad and what needs to be fixed right now
On June 3, the FDA launched OpenFDA, in an attempt to take large internal datasets […]